Paul W. Hoelscher
2020
Compensation breakdown
| Non-Equity Incentive Plan | $1,170,683 |
|---|---|
| Salary | $600,569 |
| Stock Awards | $4,037,409 |
| Other | $106,485 |
| Total | $5,915,146 |
Hoelscher received $4M in stock awards, accounting for 68% of the total pay in 2020.
Hoelscher also received $1.2M in non-equity incentive plan, $600.6K in salary and $106.5K in other compensation.
Rankings
In 2020, Paul W. Hoelscher's compensation ranked 1,775th out of 13,090 executives tracked by ExecPay. In other words, Hoelscher earned more than 86.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,775 out of 13,090 | 86th |
Division Manufacturing | 684 out of 5,621 | 88th |
Major group Chemicals And Allied Products | 245 out of 2,254 | 89th |
Industry group Drugs | 205 out of 1,954 | 90th |
Industry Pharmaceutical Preparations | 145 out of 1,459 | 90th |
Pay ratio
| Paul W. Hoelscher's Pay | $5,915,146 |
|---|---|
| Median Employee's Pay | $298,446 |
| Pay Ratio | 20to 1 |
In 2020, the annual total compensation of Paul W. Hoelscher was $5,915,146.
The annual total compensation of the median employee at Horizon Pharma was $298,446.
The ratio of Paul W. Hoelscher's pay to the pay of median employee was therefore 20 to one.
Hoelscher's colleagues
We found five more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2020.
2020
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2020
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
2020
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
2020
Barry Moze
Horizon Pharma
Chief Administrative Officer
2020
Brian Beeler
Horizon Pharma
General Counsel
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019